Intravascular ultrasound predictors for edge restenosis after newer generation drug-eluting stent implantation.
暂无分享,去创建一个
Seung‐Jung Park | G. Mintz | Young-Hak Kim | Duk‐Woo Park | Jung‐Min Ahn | Cheol-Whan Lee | G. Park | Seung‐Whan Lee | Young-Rak Cho | Soo-Jin Kang | Won-Jang Kim | Seong-Wook Park | Jong-Young Lee | Gyung-Min Park
[1] Seung‐Jung Park,et al. Intravascular ultrasound assessment of optimal stent area to prevent in‐stent restenosis after zotarolimus‐, everolimus‐, and sirolimus‐eluting stent implantation , 2014, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[2] G. Nakazawa,et al. Intravascular ultrasound criteria for determination of optimal longitudinal positioning of sirolimus-eluting stents. , 2010, Circulation journal : official journal of the Japanese Circulation Society.
[3] Seung‐Jung Park,et al. The relationship and threshold of stent length with regard to risk of stent thrombosis after drug-eluting stent implantation. , 2010, JACC. Cardiovascular interventions.
[4] P. Fitzgerald,et al. A randomized comparison of the Endeavor zotarolimus-eluting stent versus the TAXUS paclitaxel-eluting stent in de novo native coronary lesions 12-month outcomes from the ENDEAVOR IV trial. , 2010, Journal of the American College of Cardiology.
[5] Akiko Maehara,et al. Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials. , 2009, JACC. Cardiovascular interventions.
[6] G. Stone,et al. A volumetric intravascular ultrasound comparison of early drug-eluting stent thrombosis versus restenosis. , 2009, JACC. Cardiovascular interventions.
[7] G. Stone,et al. An integrated TAXUS IV, V, and VI intravascular ultrasound analysis of the predictors of edge restenosis after bare metal or paclitaxel-eluting stents. , 2009, The American journal of cardiology.
[8] P. Fitzgerald,et al. Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial. , 2008, JAMA.
[9] N. Weissman,et al. Intravascular ultrasound parameters associated with stent thrombosis after drug-eluting stent deployment. , 2007, The American journal of cardiology.
[10] P. Serruys,et al. Clinical End Points in Coronary Stent Trials: A Case for Standardized Definitions , 2007, Circulation.
[11] Young-Hak Kim,et al. Intravascular ultrasound predictors of angiographic restenosis after sirolimus-eluting stent implantation. , 2006, European heart journal.
[12] P. Fitzgerald,et al. Predictors of edge stenosis following sirolimus-eluting stent deployment (a quantitative intravascular ultrasound analysis from the SIRIUS trial). , 2005, The American journal of cardiology.
[13] G. Stone,et al. Clinical researchInterventional cardiologyStent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: An intravascular ultrasound study , 2005 .
[14] P. Fitzgerald,et al. Impact of final stent dimensions on long-term results following sirolimus-eluting stent implantation: serial intravascular ultrasound analysis from the sirius trial. , 2004, Journal of the American College of Cardiology.
[15] D. Kang,et al. Long-term outcomes of minor dissection at the edge of stents detected with intravascular ultrasound. , 2000, The American journal of cardiology.
[16] G. Stone,et al. Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. , 1999, Circulation.
[17] J. A. Painter,et al. Atherosclerosis in angiographically "normal" coronary artery reference segments: an intravascular ultrasound study with clinical correlations. , 1995, Journal of the American College of Cardiology.
[18] T. Ryan. Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty). , 1988, Journal of the American College of Cardiology.